Biosino Bio-Technology and Science Incorporation (HKG:8247)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
5.40
0.00 (0.00%)
Last updated: Mar 10, 2026, 11:27 AM HKT
881.82%
Market Cap 781.42M
Revenue (ttm) 246.61M
Net Income (ttm) -51.86M
Shares Out 144.71M
EPS (ttm) -0.36
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume 189,903
Open 5.48
Previous Close 5.40
Day's Range 5.40 - 5.48
52-Week Range 0.26 - 7.00
Beta -0.04
RSI 56.80
Earnings Date Mar 30, 2026

About HKG:8247

Biosino Bio-Technology and Science Incorporation, together with its subsidiaries, manufactures, sells, and distributes in-vitro diagnostic reagents in Mainland China. The company offers clinical chemistry reagents, including single and double reagents, calibrators, QC products, and washing solution detergents; Elisa kits; rapid tests; and analyzers. It also provides medical and medical inspection services; and produces and sells medical instruments. Biosino Bio-Technology and Science Incorporation Guangdong has a a strategic cooperation agreeme... [Read more]

Sector Healthcare
Founded 1988
Employees 471
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 8247
Full Company Profile

Financial Performance

In 2024, HKG:8247's revenue was 263.07 million, a decrease of -9.00% compared to the previous year's 289.07 million. Losses were -42.53 million, 265.1% more than in 2023.

Financial numbers in CNY Financial Statements

News

There is no news available yet.